Patents by Inventor Robert Ashley

Robert Ashley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8192749
    Abstract: A method for simultaneously treating ocular rosacea and acne rosacea in a human in need thereof comprising administering systemically to said human a tetracycline compound in an amount that is effective to treat ocular rosacea and acne rosacea but has substantially no antibiotic activity.
    Type: Grant
    Filed: November 16, 2005
    Date of Patent: June 5, 2012
    Assignee: Galderma Laboratories Inc.
    Inventor: Robert A. Ashley
  • Publication number: 20120111514
    Abstract: A process is defined for the continuous steam pretreatment and fractionation of bagasse to produce a concentrated cellulose solid stream that is sensitive to enzymatic hydrolysis. Valuable chemicals are recovered by fractionating the liquid and vapor stream composed of hydrolysis and degradation products of the hemicellulose. Cellulosic derived glucose is produced for fermentation to biofuels. A hemicellulose concentrate is recovered that can be converted to value added products including ethanol.
    Type: Application
    Filed: November 4, 2011
    Publication date: May 10, 2012
    Applicant: GREENFIELD ETHANOL INC.
    Inventors: Frank A. DOTTORI, Robert Ashley Cooper BENSON, Régis-Olivier BENECH
  • Publication number: 20120115200
    Abstract: A continuous process for the recovery of ethanol from hemicellulose and cellulose from lignocellulosic biomass. Yield of fermentable sugars can be maximized by continuous operation of the pre-treatment system and careful selection of pretreatment conditions including the addition of only small amounts of dilute mineral acid and low pressure. With this approach, the xylose component that is mainly present in its unfermentable oligomeric form in known pre-hydrolysis Kraft processes can be recovered more efficiently and as a monomer that can be fermented by xylose fermenting yeasts and bacteria. Due to the use of only dilute acids, there is a very low loss of glucose and xylose hence very low production of toxic chemicals (e.g. HMF, furfural) in the pretreatment step. The resulting overall fermentation efficiency of both hexose and pentose sugars is 90% of the theoretical maximum.
    Type: Application
    Filed: November 8, 2011
    Publication date: May 10, 2012
    Applicant: GREENFIELD ETHANOL INC.
    Inventors: Frank A. DOTTORI, Robert Ashley Cooper BENSON, Régis-Olivier BENECH
  • Publication number: 20120108552
    Abstract: A method of treating acne in a human in need thereof comprising administering systemically to said human a tetracycline compound in an amount that is effective to treat acne but has substantially no antibiotic activity, without administering a bisphosphonate compound.
    Type: Application
    Filed: October 20, 2011
    Publication date: May 3, 2012
    Applicant: GALDERMA LABORATORIES, INC.
    Inventor: Robert A. Ashley
  • Publication number: 20110318282
    Abstract: A human oral care composition, includes safe and effective amounts of the fluoride ion and stabilized chlorine dioxide, that may take the form of a paste, gel, rinse, spray, powder, varnish or similar that reduces demineralization and promotes remineralization of teeth. The method includes the topical application of the composition to the human oral cavity (including but not limited to the teeth, gingiva, and tongue), preferably at least once daily, to enhance the anti-caries effect of fluoride by released chlorine dioxido compromising any biofilm present.
    Type: Application
    Filed: December 22, 2009
    Publication date: December 29, 2011
    Applicant: MICROPURE, INC.
    Inventors: James L. Ratcliff, Lee E. Kirsch, Jessica K. Ward Dykstra, William E. Cooley, Gary Armitage, Robert Ashley, Esmeralda Ann Garcia
  • Patent number: 8052983
    Abstract: A method of treating acne in a human in need thereof comprising administering systemically to said human a tetracycline compound in an amount that is effective to treat acne but has substantially no antibiotic activity, without administering a bisphosphonate compound.
    Type: Grant
    Filed: October 22, 2007
    Date of Patent: November 8, 2011
    Assignee: Galderma Laboratories, Inc.
    Inventor: Robert A. Ashley
  • Publication number: 20110262542
    Abstract: A composition is provided for delivering a tetracycline compound to a mammal. The composition includes an antibiotic tetracycline compound and a controlled-release agent having at least one controlled-release agent. The tetracycline compound is associated with the controlled-release matrix to provide a release profile whereby the mammal is treated substantially without antibiotic activity. Methods for treating a mammal with a tetracycline compound and a dosage unit are also provided utilizing the controlled-release tetracycline composition.
    Type: Application
    Filed: July 6, 2011
    Publication date: October 27, 2011
    Applicant: GALDERMA LABORATORIES INC.
    Inventor: Robert A. Ashley
  • Patent number: 7908789
    Abstract: A container and method for storing and imparting a scent to an object. The container having an outer layer formed to define an object receiving space and fabricated of a moisture and gas barrier material. The container further having an inner scented layer having a scent incorporated therein such that, upon an object being disposed in the object receiving space, the scent of the inner scented layer is imparted to the object while the outer layer serves as a barrier to prevent surrounding objects from being contaminated with the scent.
    Type: Grant
    Filed: June 17, 2005
    Date of Patent: March 22, 2011
    Inventors: John Brandon Dobbs, Robert Ashley Dobbs
  • Publication number: 20100313882
    Abstract: A process is defined for the continuous steam pretreatment and fractionation of corn cobs and low lignin lignocellulosic biomass to produce a concentrated cellulose solid stream that is sensitive to enzymatic hydrolysis. Valuable chemicals are recovered by fractionating the liquid and vapor stream composed of hydrolysis and degradation products of the hemicellulose. Cellulosic derived glucose is produced for fermentation to biofuels. A hemicellulose concentrate is recovered that can be converted to value added products including ethanol.
    Type: Application
    Filed: April 23, 2010
    Publication date: December 16, 2010
    Applicant: GREENFIELD ETHANOL INC.
    Inventors: Frank A. Dottori, Robert Ashley Cooper Benson, Regis-Olivier Benech
  • Publication number: 20100269990
    Abstract: A process for separating the components of lignocellulosic biomass for the purpose of producing a pure reactive cellulose is disclosed. The process has two stages. In the first stage, the lignocellulosic biomass is pretreated with steam, with or without an acid catalyst, and then pressed, with or without the presence of an eluent, to remove hemicellulose and other impurities. In the second stage, the pretreated biomass is extracted with a solvent such as ethanol with or without acid catalysts in order to remove lignin and release a purified cellulose stream. The extracted cellulose is then rapidly decompressed to rupture the fibrous structure. The process provides a purified cellulose stream that is relatively easy to hydrolyze with enzymes and ferment to biofuels and other chemicals such as ethanol.
    Type: Application
    Filed: April 23, 2010
    Publication date: October 28, 2010
    Applicant: GREENFIELD ETHANOL INC.
    Inventors: Frank A. DOTTORI, Robert Ashley Cooper BENSON, Régis-Olivier BENECH
  • Publication number: 20100263814
    Abstract: A process for the pretreatment of lignocellulosic biomass is disclosed. The process is intended for use in connection with biomass to ethanol processes and is directed in particular to an economical removal of inhibitory compounds generated in biomass pretreatment, which are inhibitory to downstream hydrolysis and fermentation steps. The process includes the steps of heating the lignocellulosic biomass with steam to a preselected temperature, at a preselected pressure and for a preselected time to hydrolyze and solubilize hemicelluloses in the biomass; explosively decomposing the biomass into fibers; and extracting from the resulting reaction mixture a liquefied portion of the lignocellulosic biomass before or after explosive decomposition. The liquefied portion is extracted to remove compounds from the lignocellulosic biomass which are inhibitory to enzymatic cellulose hydrolysis and sugar fermentation to ethanol. For improved efficiency and economy, the inhibitory compounds are not completely removed.
    Type: Application
    Filed: April 7, 2010
    Publication date: October 21, 2010
    Applicant: GREENFIELD ETHANOL INC.
    Inventors: Frank A. DOTTORI, Robert Ashley Cooper BENSON, Régis-Olivier BENECH
  • Publication number: 20100255554
    Abstract: A method for optimization of a fed batch hydrolysis process wherein the hydrolysis time is minimized by controlling the feed addition volume and/or batch addition frequency of the prehydrolysate and optionally also the enzyme feed. The increase over time in hydrolysate consistency and volume and/or concentration of sugars released in the reactor, so that the enzymatic hydrolysis is controlled, significantly reduces the impact of cellulase feedback inhibition, especially for enzyme contents lower than 0.5%. The overall time to reach conversion of the total prehydrolysate feed is reduced significantly where the batch addition frequency is equal to one batch each time 70% to 90%, preferably 80%, conversion of the previous batch is reached in the reaction mixture. At an enzyme load of 0.3% in the reaction mixture, the optimum frequency each time 80% conversion was reached was found to be one batch every 105 minutes.
    Type: Application
    Filed: March 31, 2010
    Publication date: October 7, 2010
    Applicant: GREENFIELD ETHANOL INC.
    Inventors: Robert Ashley Cooper BENSON, Regis-Olivie BENECH
  • Publication number: 20100159552
    Abstract: A process for the production of ethanol wherein a hydrolyzed lignocellulosic biomass is fermented in the presence of a stillage residue. The fermentation of cellulosic hydrolysates is improved by adding prior to and/or during fermentation a stillage residue side stream from a corn starch-to-ethanol process as a nutrient source for the yeast organisms used in the fermentation. Stillage residues from the grain dry mill ethanol producing process, including the whole stillage, wet cake, thin stillage, and/or syrup are added to assist as a nitrogen and nutrient source for the fermentive processes. The stillage residue is produced by any grain-to-ethanol process.
    Type: Application
    Filed: December 22, 2009
    Publication date: June 24, 2010
    Applicant: GREENFIELD ETHANOL INC.
    Inventors: Robert Ashley Cooper BENSON, Régis-Olivier Benech
  • Publication number: 20090137845
    Abstract: The present invention provides new chemically modified 4-dedimethylaminotetracycline compounds that can be substituted with aryl, alkenyl, or alkynyl groups. The 7, 8, and/or 9 positions and methods for preparing such compounds. Other tetracycline compounds include the 4-dedimethylaminotetracycline derivatives with an oxime group, NH-Alkyl, or N—NH-Alkyl group substituted at the C4 position as well as C2 Mannich derivatives. The present invention also provides a method of treating a mammal suffering from conditions or diseases by administering to the mammal an effective amount of the new chemically modified tetracycline compounds.
    Type: Application
    Filed: October 23, 2008
    Publication date: May 28, 2009
    Inventors: Robert Ashley, Joseph J. Hlavka
  • Patent number: 7456158
    Abstract: The present invention provides new chemically modified 4-dedimethylaminotetracycline compounds that can be substituted with aryl, alkenyl, or alkynyl groups. The 7, 8, and/or 9 positions and methods for preparing such compounds. Other tetracycline compounds include the 4-dedimethylaminotetracycline derivatives with an oxime group, NH-Alkyl, or N—NH-Alkyl group substituted at the C4 position as well as C2 Mannich derivatives. The present invention also provides a method of treating a mammal suffering from conditions or diseases by administering to the mammal an effective amount of the new chemically modified tetracycline compounds.
    Type: Grant
    Filed: January 5, 2005
    Date of Patent: November 25, 2008
    Assignee: Galderma Laboratories, Inc.
    Inventors: Robert Ashley, Joseph J. Hlavka
  • Publication number: 20080171727
    Abstract: A method of treating acne in a human in need thereof comprising administering systemically to said human a tetracycline compound in an amount that is effective to treat acne but has substantially no antibiotic activity, without administering a bisphosphonate compound.
    Type: Application
    Filed: October 22, 2007
    Publication date: July 17, 2008
    Inventor: Robert A. Ashley
  • Patent number: 7232572
    Abstract: A method of treating rosacea in a human in need thereof comprising administering to said human a tetracycline compound in an amount that is effective to treat rosacea, but has substantially no antibiotic activity.
    Type: Grant
    Filed: February 18, 2005
    Date of Patent: June 19, 2007
    Assignee: CollaGenex Pharmaceuticals, Inc.
    Inventor: Robert A. Ashley
  • Patent number: 7210411
    Abstract: A round of ammunition for firing from a gun having a rifled barrel, especially a small arms weapon. The projectile (1) forming a part of the round is of steel or other material having a Vickers Hardness value not less than 550, and has a coating (13) of copper or copper alloy. The projectile has a forward body portion (9) which has a diameter similar to that of the lands of the rifling, and a rearward body portion (3) having a diameter which is similar to the diameter defined by the roots of the rifling grooves. The coating (13) is of a thickness not less than the depth of the said rifling grooves, so that the rifling engraves the coating but does not significantly engrave the underlying steel or other hard material. The advantages associated with a hard projectile material are thus obtained without substantially increasing barrel wear.
    Type: Grant
    Filed: March 16, 2004
    Date of Patent: May 1, 2007
    Assignee: BAE Systems plc
    Inventors: Derek Booth, Adrian David Smith, Robert Ashley
  • Patent number: 7211267
    Abstract: A method of treating acne in a human in need thereof comprising administering systemically to said human a tetracycline compound in an amount that is effective to treat acne but has substantially no antibiotic activity, without administering a bisphosphonate compound.
    Type: Grant
    Filed: April 5, 2002
    Date of Patent: May 1, 2007
    Assignee: CollaGenex Pharmaceuticals, Inc.
    Inventor: Robert A. Ashley
  • Publication number: 20060094697
    Abstract: A method for simultaneously treating ocular rosacea and acne rosacea in a human in need thereof comprising administering systemically to said human a tetracycline compound in an amount that is effective to treat ocular rosacea and acne rosacea but has substantially no antibiotic activity.
    Type: Application
    Filed: November 16, 2005
    Publication date: May 4, 2006
    Inventor: Robert Ashley